219 related articles for article (PubMed ID: 18381472)
1. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Freedman DM; Chang SC; Falk RT; Purdue MP; Huang WY; McCarty CA; Hollis BW; Graubard BI; Berg CD; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):889-94. PubMed ID: 18381472
[TBL] [Abstract][Full Text] [Related]
2. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
[TBL] [Abstract][Full Text] [Related]
3. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
[TBL] [Abstract][Full Text] [Related]
5. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
6. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
7. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
8. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
[TBL] [Abstract][Full Text] [Related]
9. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
11. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE
Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600
[TBL] [Abstract][Full Text] [Related]
13. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT
Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
15. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Ahn J; Albanes D; Peters U; Schatzkin A; Lim U; Freedman M; Chatterjee N; Andriole GL; Leitzmann MF; Hayes RB;
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2623-30. PubMed ID: 18086766
[TBL] [Abstract][Full Text] [Related]
16. Plasma vitamin D metabolites and risk of colorectal cancer in women.
Feskanich D; Ma J; Fuchs CS; Kirkner GJ; Hankinson SE; Hollis BW; Giovannucci EL
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1502-8. PubMed ID: 15342452
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
[TBL] [Abstract][Full Text] [Related]
18. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
19. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
20. Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women.
Palmer JR; Gerlovin H; Bethea TN; Bertrand KA; Holick MF; Ruiz-Narvaez EN; Wise LA; Haddad SA; Adams-Campbell LL; Kaufman HW; Rosenberg L; Cozier YC
Breast Cancer Res; 2016 Aug; 18(1):86. PubMed ID: 27520657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
